High Purity Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate | Trusted Supplier

Discover a critical pharmaceutical intermediate essential for Febuxostat synthesis. We are your reliable manufacturer and supplier in China, offering high purity and consistent quality for your drug development needs.

Get a Quote & Sample

Advantages of Sourcing Our Pharmaceutical Intermediate

Uncompromised Quality Assurance

Our Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate undergoes rigorous quality control to meet pharmaceutical standards, giving you confidence in your synthesis process. We offer comprehensive documentation including COA, ROS, MSDS, and MOA to support your regulatory requirements.

Stable Supply Chain and Competitive Pricing

Partner with a reliable Chinese manufacturer and supplier to secure a consistent and cost-effective supply of this crucial intermediate. We understand the importance of timely delivery to keep your production schedules on track.

Expert Technical Support

Leverage our expertise as a fine chemical manufacturer. We provide essential technical data and support to assist your R&D and production teams in effectively utilizing our products for your Febuxostat synthesis.

Primary Application: Febuxostat Synthesis

Febuxostat Intermediate

Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate is a primary intermediate in the multi-step synthesis of Febuxostat, a potent xanthine oxidase inhibitor used for managing hyperuricemia and chronic gout.

Pharmaceutical Manufacturing

This compound serves as a vital building block for pharmaceutical companies engaged in the production of active pharmaceutical ingredients (APIs), ensuring the quality and effectiveness of medications targeting conditions like gout.

Organic Synthesis Research

Beyond its direct pharmaceutical application, this intermediate is valuable in organic chemistry research for developing new synthetic routes and exploring related chemical structures.

Quality Control & Standards

Used as a reference standard and for impurity profiling in the quality control of Febuxostat production, ensuring the safety and efficacy of the final drug.